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ATP-binding cassette (ABC) transporters have
been implicated in a multitude of biological
pathways. In plants, some ABC transporters
are involved in the polar transport of the plant
hormone auxin and the gravitropic response.
We previously identified Gravacin as a potent
inhibitor of gravitropism in Arabidopsis thali-
ana. We demonstrate that P-glycoprotein19
(PGP19) is a target for Gravacin and partici-
pates in its inhibition of gravitropism. Grava-
cin inhibited the auxin transport activity of
PGP19 and PGP19-PIN complexes. Further-
more, we identified E1174 as an important
residue for PGP19 activity and its ability to
form active transport complexes with PIN1.
Gravacin is an auxin transport inhibitor that
inhibits PGPs, particularly PGP19, which can
be used to further dissect the role of PGP19
without the inhibition of other auxin trans-
porters, namely PIN proteins.
INTRODUCTION
ATP-binding cassette (ABC) transporters comprise one of
the largest families of proteins in most organisms, are
mostly membrane associated, and couple ATP hydrolysis
to the transport of a multitude of compounds across bio-
logical membranes. In eukaryotes, ABC transporters
have been implicated in the transport of ions, sugars, pep-
tides, and xenobiotics [1]. The founding ABC transporter,
human multidrug resistance/P-glycoprotein (MDR1/P-gp),
and other ABC transporters have been implicated in mul-
tidrug resistance in cancer and the development of several
diseases such as cystic fibrosis [2]. In plants, ABC trans-
porters translocate a diverse array of molecules including
the plant hormone auxin, lipids, xenobiotics, and second-
ary metabolites (reviewed in [3]). Arabidopsis P-glycopro-
tein PGP19 (PGP19/MDR1/ABCB19) and PGP1 belong to
the ABC type B transporter/multidrug resistance/P-glyco-1366 Chemistry & Biology 14, 1366–1376, December 2007 ª2protein family of proteins (TC 3.A.1) [4, 5] and together with
the PIN-FORMED (PIN) family of proteins have auxin efflux
activity [6–9]. PIN proteins are transmembrane proteins
that belong to the auxin efflux carrier family (TC 2.A.69)
[10, 11], and primarily regulate the basal levels of direc-
tional auxin transport required for polar development [10,
12, 13]. PGP19andPGP1were isolated fromdetergent-re-
sistant microdomains (DRMs) of Arabidopsis microsomal
fractions that bind the polar auxin transport inhibitor naph-
thylphthalamic acid (NPA) [14, 15]. Analysis of pgp19 and
pgp1 mutants indicated that PGP19 and PGP1 function
as auxin transporters in shoots and roots [15–17]. PGP19
has been shown to function primarily in basipetal transport
along the embryonic shoot to root apical axis [16, 18–20]
with an additional localized role in movement of auxin in
the lateral root cap cells above the columella and below
the elongation zone [7, 20]. Loss of PGP19 function results
in eccentric linear root growth, but has no effect in short-
term root gravitropism [19]. PGP19 is localized to the shoot
apex and the vascular tissues in light-grown hypocotyls,
and its expression is upregulated throughout most of the
hypocotyl in dark-grown seedlings [20]. In roots, PGP19
expression and abundance in cells involved in differential
auxin movement in gravitropic responses are low or not
detectable [7, 18, 20].
Auxin is synthesized at the shoot apex as well as in leaf
and root primordia [21]. Auxin from the shoot apex is
loaded into a stream of basipetal auxin flow along the
embryonic axis that reaches the root tip via the vascular
cylinder. Because auxin influx can occur by passive up-
take, directional auxin flow is defined primarily by the polar
activity of efflux carriers [19–22], except at the root tip,
where the AUX1 H+ auxin uptake symporter is involved
[23, 24]. PIN and PGP proteins appear to act as indepen-
dent auxin efflux carriers and are sensitive to auxin trans-
port inhibitors, but they show reduced substrate and
inhibitor specificity when expressed alone in nonplant het-
erologous systems [9]. The synergistic interaction of PIN
and PGP proteins may provide the specificity and high
rate of auxin transport necessary to generate a long-
distance transport stream [19]. This model is supported
by genetic interactions between PIN and PGPs and by
coimmunoprecipitation and yeast two-hybrid assays.007 Elsevier Ltd All rights reserved
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PGP19 Is a Target of GravacinCoexpression of PIN1 with PGP19 or PGP1 in HeLa cells
results in a synergistic effect on auxin transport quantity
and specificity in this system [20].
Plants respond to changes in gravitropic stimuli to en-
sure access to resources after strong winds or heavy
rain. Sedimentation of starch-filled amyloplasts (statoliths)
in gravistimulated columella cells of the root cap or the
endodermis of hypocotyls triggers organ bending to align
the plant axis with the gravity vector [25]. The plant auxin
indole acetic acid (IAA) is the primary hormonal signal that
regulates organ curvature by inducing differential growth
between the upper and lower parts of gravistimulated tis-
sues. Soon after gravistimulation, a gradient of auxin ac-
cumulation is formed between upper and lower parts of
roots and hypocotyls [26–29], and differential polar auxin
transport streams are required for this effect. In shoots,
increased endogenous auxin levels promote cellular elon-
gation, whereas in roots, localized differential auxin accu-
mulations in the elongation zone inhibit elongation growth.
The precise mechanisms involved in lateral redistribu-
tion of auxin in gravistimulated tissues are still poorly
understood. As auxin is a weak acid and its transport is
motivated by chemiosmotic potentials, rapid differential
activation of plasma membrane H+ ATPases may contrib-
ute to lateral redirection [30]. In roots, redirection of auxin
flows appears to be partially controlled by dynamic reloc-
alization of PIN3 as well as internalization and proteolysis
of PIN2 [31–33]. Less is known about the mechanisms of
lateral auxin redirection in graviresponding hypocotyls.
Tropic bending in hypocotyls may also involve PIN3 [33],
and lateral auxin redistribution may involve interruption
of PIN1- and PGP19-mediated downward auxin transport,
especially as loss of PGP19 function enhances tropic
bending [20, 34, 35].
We recently identified 3-(5-[3,4-dichlorophenyl]-2-furyl)-
acrylic acid (PubChem compound ID 776105, Chem-
Bridge ID 5850247, herein referred to as Gravacin for
gravitropism and vacuolar transport inhibitor) as a strong
inhibitor of root and shoot gravitropism, auxin responsive-
ness, and protein trafficking to the tonoplast in Arabidop-
sis [36]. Here we describe the identification of PGP19 as
a target of Gravacin. We show that mutations in PGP19
confer resistance to the effect of Gravacin on hypocotyl
gravitropism and result in reduced binding of Gravacin
to microsomal fractions. Gravacin was found to be a
strong inhibitor of PGP19-mediated polar auxin transport
in Arabidopsis and HeLa cells.
RESULTS
Gravacin Inhibits Gravitropism and Protein
Trafficking via Independent Mechanisms
We initially identified Gravacin by screening a combinato-
rial library for effects on the gravitropic response of Arabi-
dopsis seedlings [36]. Gravacin strongly inhibited gravi-
tropism and blocked the trafficking of the tonoplast
marker GFP-dTIP to the vacuolar membrane [36]. Thus,
the GFP-dTIP marker displays a pattern similar to that of
markers for the endoplasmic reticulum (ER) when seed-Chemistry & Biology 14, 1366–13lings are grown in the presence of Gravacin [36]. We
tested the effect of eight compounds that were structurally
similar to Gravacin (SciFinder Scholar, American Chemi-
cal Society) to understand the activity of Gravacin in these
two pathways (Table 1). The effect of these compounds on
gravitropism was assayed by quantification of the hypo-
cotyl curvature in gravistimulated seedlings in the pres-
ence of 0.1, 1, or 10 mM each compound. Only Gravacin
and compound A had strong inhibitory effects on gravi-
tropism, and 1 mM was sufficient to inhibit the gravitropic
response in hypocotyls (Table 1). The effect of these com-
pounds on the trafficking of the GFP-dTIP marker was
tested at 0, 2.5, 5, 10, and 35 mM. A minimum of 10 mM
Gravacin was necessary to induce the ER-like appearance
of the GFP-dTIP marker. In contrast, only 2.5 mM was
needed to induce a similar phenotype with compounds
C, D, E, and G, and 5 and 10 mM compounds A and F,
respectively. However, compound B required 35 mM to
induce this phenotype. Out of the eight compounds tested
overall, only Gravacin and compound A were effective in-
hibitors of both pathways. We conclude that the chemical
domains of Gravacin and its analogs that are required for
inhibition of gravitropism and tonoplast protein trafficking
are different, and independent targets must be responsi-
ble for the effects in each pathway.
Screen for Gravacin-Resistant Mutants
In order to identify the target of Gravacin responsible for
the gravitropic phenotype, we conducted a genetic screen
for mutants resistant to this effect. About 220,000 seeds
from M2 mutagenized plants in the GFP-dTIP background
[37] were screened in a gravitropic assay for resistance
to 1.7 mM Gravacin, a concentration that inhibits the
gravitropic response of Arabidopsis hypocotyls [36]
(Figure 1A). Seven resistant lines that were responsive to
gravitropism in the presence of Gravacin were identified
but only three lines showed strong resistant phenotypes,
and were named Gravacin-resistant for gravitropism
(grav-r) (Figure 1A). Treatment of GFP-dTIP seedlings
with 1.3 mM Gravacin resulted in a random distribution of
hypocotyl orientations even 24 hr after a 90 reorientation,
which indicates a strong inhibition of the gravitropic re-
sponse (Figure 1B). In contrast, the orientations for over
60% of the GFP-dTIP hypocotyls in the DMSO control
were 30–90 from the gravity vector prior to reorientation.
The grav-r1 line is resistant to Gravacin, as over 90% of
seedlings displayed hypocotyl curvatures between 30
and 90 in the Gravacin treatment (Figure 1B). Analysis
of seedling extracts ruled out the possibility that the resis-
tant phenotype of grav-r1 was due to reduced uptake or
abnormal metabolism of Gravacin (see the Supplemental
Data available with this article online), and this line was
selected for further characterization.
The grav-r1 Mutation Maps to the PGP19 Locus
A map-based cloning approach was used to identify the
mutation in grav-r1. Forty-nine resistant mutants were
identified in a mapping population of 301 F2 segregating
seedlings (1:6.14) using the gravitropic assay indicating76, December 2007 ª2007 Elsevier Ltd All rights reserved 1367
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PGP19 Is a Target of GravacinTable 1. Activity of Gravacin Analogs on Gravitropism and the Targeting of the GFP-dTIP Marker
Name PubChem CID Numbers Chemical Structures Gravitropism (mM) GFP-dTIP Targeting (mM)
Gravacin 776105 1 10
A 744897 1 5
B 876446 N/A 35
C 1106183 N/A 2.5
D 643402 N/A 2.5
E 617688 N/A 2.5
F 931655 N/A 10
G 736257 N/A 2.5
Compound identification (CID) numbers from PubChem are indicated. The numbers represent theminimum concentration at which
an inhibitory effect was detected for each phenotype. Effect on hypocotyl gravitropism was tested at 0.1, 1, and 10 mM. GFP-dTIP
targeting was tested at 0, 2.5, 5, 10, and 35 mM each chemical. N/A, no effect detected.that the phenotype was due to a single recessive muta-
tion. Rough mapping with SSLP markers [38] placed the
mutation in chromosome 3 between markers ciw11
and ciw4. Fine mapping defined an interval of 639 kb
containing the mutation between markers GL1 and
MASC1094. This region contained the candidate gene
P-GLYCOPROTEIN (PGP) 19, a multidrug resistance
ABC transporter that has been implicated in auxin efflux
[15]. This gene was sequenced in the grav-r1 mutant and
a G to A substitution was found in the last exon of the
gene, 6761 bp downstream of the start codon in the geno-1368 Chemistry & Biology 14, 1366–1376, December 2007 ª20mic sequence (Figure 1C). This results in a substitution of
Glu1174 for Lys (E1174K) at a position adjacent to the pre-
dicted Walker B motif of the ATP-binding cassette of
this protein (VLLLDE). We named this allele pgp19-4
(Figure 1C).
To determine whether the mutation in PGP19 was
responsible for the Gravacin-resistant phenotype of
pgp19-4, three other mutant alleles, pgp19-1 (also known
as pgp19 or mdr1-1) [15], mdr1-100, and mdr1-101 [39]
(Figure 1C) were tested in the gravitropic assay in the
presence of Gravacin. These knockout alleles display07 Elsevier Ltd All rights reserved
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PGP19 Is a Target of GravacinFigure 1. gravacin-r1 Mutants Are Resistant to the Gravi-
tropic Inhibition of Gravacin
(A) Gravacin inhibits gravitropic response of hypocotyls from the
parental line (GFP-dTIP) but not of the gravacin-r1 (grav-r1) mutant.
Seeds from the GFP-dTIP parental line (top) and grav-r1 mutant (bot-
tom) were plated in the presence of DMSO (control, left) or 1.3 mM
Gravacin (right) and 3-day-old seedlings were gravistimulated in the
dark for 24 hr. Gravitropic vectors before (g1) and after (g2) reorienta-
tion are indicated.
(B) Quantification of the gravitropic response of the parental line (GFP-
dTIP) and the grav-r1 mutant. The experiment was done exactly as in
(A). The angle formed between the upper hypocotyl of each seedling
and the gravitropic vector before reorientation (g1) was measured
and assigned to one of six 60 sectors (330–30, 30–90, 90–
150, 150–210, 210–270, or 270–330). The small inset shows
examples of the angle (a) used to measure hypocotyl orientation.
Results are presented as the percentage of seedlings in each sector
(n = 70–100 seedlings).
(C) The grav-r1/pgp19-4 mutant line carries a G/A substitution in
exon X of the pgp19 coding sequence, 6761 bp downstream of the
start codon. The T-DNA insertions in pgp19-1, mdr1-100, and mdr1-
101 are indicated.Chemistry & Biology 14, 1366–137enhanced hypocotyl gravitropism under normal condi-
tions [34, 39]. Gravacin strongly inhibited the gravitropic
response of the wild-type control Wassilewskija (Ws) but
not that of the pgp19-1 mutants (Figure 2), indicating
that pgp19-1 is also resistant to Gravacin. Similarly,
mdr1-100 and mdr1-101 were also resistant to Gravacin
(Figure S2). In comparison, a mutation in the closely
related P-glycoprotein PGP1 did not confer resistance to
the chemical, as pgp1 mutants responded similarly as
the wild-type when exposed to Gravacin (Figure 2). Similar
to the pgp19-1 (Figure 2) and pgp19-4 (Figure 1B) mu-
tants, the pgp1 pgp19-1 double mutant was also resistant
to Gravacin (Figure 2). These results together confirm that
the mutation in PGP19 of pgp19-4 is responsible for its
Gravacin-resistant phenotype.
It has been shown that the immunophilin-like TWISTED
DWARF 1 (TWD1) protein interacts with both PGP19 and
PGP1, and is required for their activity in planta [16].
Thus, several phenotypes observed in pgp1 pgp19-1 dou-
ble mutants are recapitulated in twd1. We then tested
whether twd1 mutants were resistant to Gravacin in the
gravitropic assay, and indeed these seedlings were resis-
tant to Gravacin as the pgp19-1, pgp19-4, and pgp19
pgp1 double mutants (Figure 2), indicating that both
TWD1 and PGP19 but not PGP1 are required for the effect
of Gravacin on gravitropism.
Effect of Gravacin on PGP-Mediated
Auxin Transport
PGP19 was identified as a plasma membrane protein that
binds the noncompetitive polar auxin transport inhibitor
NPA [14, 15], and both PGP19 and PGP1 are required
for auxin transport in shoots [15, 16]. Furthermore,
PGP19 and PGP1 expressed in HeLa and tobacco-BY-2
cells are able to export auxin, and this activity is reduced
by NPA [6, 7, 9]. Given the role of PGP19 in auxin trans-
port, we wanted to determine the effect of the pgp19-4
mutation and that of Gravacin in this process. Transport
of radiolabeled auxin from the shoot apex to the shoot-
root transition zone was used to measure shoot basipetal
auxin transport in each genotype [16]. Basipetal auxin
transport was significantly reduced in 5-day-old pgp19-
1, pgp1 pgp19, double and pin1 mutant seedlings when
compared to wild-type as has previously been described
[15, 16] (Figure 3A, black bars). Consistent with previous
reports [15, 16] and under the conditions used, pgp1
mutants showed only a slight decrease in auxin transport.
Similar to pgp19-1, the pgp19-4 allele exhibited a 50%
reduction in basipetal auxin transport when compared to
its parental control (GFP-dTIP in Col-0), indicating an im-
portant role of E1174 in the auxin transport activity of
PGP19. To determine the effect of Gravacin in auxin trans-
port, seedlings were exposed to 30 mM Gravacin for 2 hr
prior to auxin transport measurements (Figure 3A, white
bars). A 50% reduction in basipetal auxin transport was
observed in wild-type Ws seedlings when treated with
Gravacin. Treatment with lower concentrations of Grava-
cin or Gravacin treatments of shorter intervals resulted in
lesser reductions in transport. However, when pgp19-16, December 2007 ª2007 Elsevier Ltd All rights reserved 1369
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PGP19 Is a Target of Gravacinor pgp19-1 pgp1 double mutants were used, the reduc-
tion in transport due to the chemical was not significantly
different from the untreated controls, indicating that
PGP19 is required for the inhibition of auxin transport by
Gravacin. When seedlings of pin1 or pgp1 mutants were
assayed in the presence of Gravacin, the reduction in
transport was between 30% and 50% of the correspond-
ing untreated control. TheGFP-dTIP line in theCol-0 back-
ground was also affected by Gravacin treatment; how-
ever, transport was reduced only by 40%. Similar to
pgp19-1 and pgp19-1 pgp1 doublemutants, the basipetal
auxin transport in hypocotyls of pgp19-4mutants was not
affected by Gravacin treatment when compared to the
Figure 2. Mutations in PGP19 Confer Resistance to Gravacin
Seeds from wild-type Ws, pgp19-1, pgp1, pgp1 pgp19-1 double
mutant, and twd1 were tested in a gravitropic assay in the absence
(left, DMSO) or presence (right) of 1 mM Gravacin. The gravitropic
response was assayed as in Figure 1B, except that twd1 data only
include 30–40 seedlings per treatment.1370 Chemistry & Biology 14, 1366–1376, December 2007 ª20Figure 3. Gravacin Inhibits Auxin Transport
(A) The pgp19-4 mutation and treatment with Gravacin have an effect
on auxin transport inArabidopsis shoots. Basipetal transport of [3H]IAA
in Arabidopsis hypocotyls from wild-type Ws, pgp19-1, pgp1, pgp1
pgp19-1, pin1, the parental line GFP-dTIP (ecotype Col-0), and
pgp19-4 in the presence of DMSO (black bars) or 30 mM Gravacin
(white bars). Data represent mean ± SD (n = 10). Significant differences
were determined by ANOVA followed by Tukey post-hoc analysis (a,
different from corresponding wild-type control; b, different from the
DMSO-treated value of the same genotype, p < 0.05).
(B) Effect of Gravacin on the auxin efflux activity of HeLa cells express-
ing PGP19, PGP1, PIN1, PIN2, or coexpressing PGP19 and PIN1
(PGP19 + PIN1). Cells were incubated with 25 nM [3H]IAA alone (black
bars), 25 nM [3H]IAA and 5 mMGravacin (white bars), or 25 nM [3H]IAA
and 5 mM NPA (crossed bars). Data represent mean ± SD. Significant
differences between the IAA control and each treatment are indicated
(ANOVA and Tukey post-hoc analysis: *p < 0.01, **p < 0.1).
(C) Effect of the E1174K substitution and Gravacin treatment on auxin
efflux activity of PGP19 in HeLa cells. Net efflux of [3H]IAA in HeLa cells
expressingPGP19orpgp19E1174Kproteins incubatedwith15nM (black
bars) or 81.5 nM (white bars) [3H]IAA alone, or 15 nM [3H]IAA and 5 mM
Gravacin (crossed bars). Data represent mean ± SD. Significant differ-
encesweredeterminedbyANOVAandTukeypost-hocanalysis (a,differ-
ent from the empty vector control; b, different from the corresponding
15 nM IAA treatment; c, coexpressed PGP19 + PIN1 (or pgp19E1174K +
PIN1 was different from the corresponding PGP19 alone, p < 0.05).07 Elsevier Ltd All rights reserved
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acin inhibits basipetal auxin transport in wild-type hypo-
cotyls via the inhibition of PGP19 activity.
The capacity of PIN2, PIN7, PGP1, and PGP19 to trans-
port auxin independently in a heterologous system has
been demonstrated [6, 7, 9, 20], and the synergistic inter-
action of PIN1 with PGP19 in the same system indicated
that PIN-PGP interactions play a role in defining the spec-
ificity and rate of molecular transport [20]. We took advan-
tage of this system to determine the effect of Gravacin on
the efflux activity of individual transporters and co-
expressed PGP19 and PIN1. PGP19, PGP1, PIN1, and
PIN2 proteins were expressed in HeLa cells and the net ef-
flux of radiolabeled auxin with and without 5 mM Gravacin
or NPA was analyzed. As has been described previously,
expression of PGP19, PGP1, and PIN2 results in signifi-
cant net auxin efflux, but expression of PIN1 alone results
in no detectable transport [6, 20] (Figure 3B). Similarly, co-
expression of PGP19 and PIN1 resulted in a synergistic
increase in auxin efflux [20]. Gravacin reduced the trans-
port activity of PGP19 by 45% and that of PGP1 by almost
30%, but did not affect PIN2 transport. Auxin efflux was
inhibited by Gravacin in cells expressing PGP19 + PIN1,
which indicates that Gravacin may disrupt the interaction
of PGP19 with other proteins. Concentrations of Gravacin
higher than 5 mM (up to 30 mM) were not used because
they increased IAA retention in all cells, decreased cell ad-
hesion, and increased other visible symptoms of cellular
toxicity. In contrast to Gravacin and consistent with previ-
ous results [9, 20], 5 mM NPA inhibited the auxin transport
mediated by PIN2. NPA treatment also reduced the levels
of auxin transport by PGP1, PGP19, and PIN1 + PGP19 to
similar levels as Gravacin. Interestingly, 5 mM Gravacin
has less of an effect on background HeLa cell transport
activated by PIN1 expression [9, 20] than the same con-
centration of NPA, which highlights a higher specificity
of Gravacin for PGP19. The effect of the E1174K substitu-
tion from pgp19-4 was also tested in this system
(Figure 3C). Expression of PGP19 harboring the mutation
observed in pgp19-4 (pgp19E1174K) resulted in similar
IAA efflux activity when cells were incubated with 15 nM
[3H]IAA. However, cells expressing pgp19E1174K showed
a 70% decrease in auxin transport compared to wild-
type PGP19 when 81.5 nM [3H]IAA was used (Figure 3C).
This large difference was due in part to the increased
transport activity of wild-type PGP19 at high auxin con-
centration, which was not observed in cells expressing
pgp19E1174K. This indicates that E1174 is important for
the modulation of auxin efflux activity of PGP19 with vary-
ing concentrations of auxin. Coexpression of pgp19E1174K
with PIN1 did not result in the synergistic increase of trans-
port that has been previously observed in cells coexpress-
ing PGP19 and PIN1 both at 15 and 82 nM [3H]IAA (Fig-
ure 3C), which points toward E1174 as an important
residue involved in PGP19 interactions with PIN1. Treat-
ment with 5 mM Gravacin resulted in inhibition of efflux
activity in cells expressing PGP19, pgp19E1174K, and
pgp19E1174K + PIN1. Experiments from Figure 3C were
conducted using purified [3H]IAA which results inChemistry & Biology 14, 1366–137increased loading into cells and increased the sensitivity
of the assay.
Gravacin Binds PGP19 in ArabidopsisMicrosomes
Microsomal fractions containing PGP19 have been shown
to bind NPAwith high affinity [14]. Thus, we askedwhether
Gravacin could compete with NPA for binding to Arabi-
dopsis microsomes. Microsomes from wild-type Ws,
pgp19-1, pgp1, and pin1 mutants were incubated with
20 nM [3H]NPA alone or [3H]NPA and 100 nM Gravacin.
To determine specific binding activity, the experiments
were repeated in the presence of 20 mM cold NPA and
residual binding was subtracted. Figure 4A shows that,
when incubated with NPA alone (black bars), wild-typemi-
crosomes exhibit specific NPA binding of approximately
100 fmol [3H]NPA/mg total protein in this assay. NPA bind-
ing was reduced in pgp19-1 microsomes by about 50%
when compared to wild-type, indicating that PGP19 is
important for specific NPA binding to Arabidopsis micro-
somes. NPA binding did not significantly change in pgp1
and pin1 microsomes when compared to the wild-type
control. When microsomes from wild-type Ws seedlings
were incubated with both NPA and Gravacin (white
bars), more than 60% of the NPA bound to microsomes
was displaced by Gravacin. No significant displacement
of [3H]NPA by Gravacin was observed in microsomes iso-
lated from pgp19-1 seedlings, suggesting that [3H]NPA
bound to PGP19 is what is primarily displaced byGravacin
in the wild-type. This was further supported by results
from the pgp1 or pin1 mutants which were very similar
to the wild-type (Figure 4A).
To further ascertain whether PGP19 directly bindsGrav-
acin and is responsible for its effect on seedling auxin
transport, we assayed Gravacin binding to microsomal
fractions from wild-type plants and from the two mutant
alleles pgp19-1 and pgp19-4. Microsomal fractions from
each genotype were incubated with 15 mM Gravacin. Un-
bound Gravacin was removed by a series of washes in
buffer lacking Gravacin, and bound chemical was mea-
sured by absorbance at 348 nm (Supplemental Data).
Wild-type microsomes retained 40–47 pmol Gravacin/
mg total protein (Figure 4B). Binding of Gravacin was sig-
nificantly reduced in microsomes from pgp19-1 and
pgp19-4 mutants compared to the corresponding con-
trols wild-type Ws and GFP-dTIP, respectively. A signifi-
cant decrease in Gravacin binding was also seen in
twd1, indicating that TWD1 is involved, even if indirectly,
in Gravacin binding to microsomes. Overall, these results
are consistent with Gravacin binding to PGP19 and with
the interpretation that the gravitropism resistance pheno-
type of pgp19-4 hypocotyls is due to reduced binding of
the chemical to the mutant pgp19E1174K protein. However,
the extent of Gravacin binding exceeds the apparent
PGP19 protein content of wild-type microsomes as indi-
cated by ELISAs (B.T., J.B., and A.S.M., unpublished
data) and by NPA displacement experiments, suggesting
that loss of PGP19 function impacts binding of Gravacin to
other targets as well. This may be a result of the altered
membrane characteristics previously observed in6, December 2007 ª2007 Elsevier Ltd All rights reserved 1371
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PGP19 Is a Target of Gravacinpgp19-1 (B.T., J.B., and A.S.M., unpublished data). Fur-
thermore, the saturating levels of Gravacin that were
used for this assay may result in aggregation of Gravacin
molecules at the plasma membrane as was previously
described for NPA in similar experiments [40].
Gravacin Affects Localization of a GFP Fusion
to PGP19
The effect of Gravacin on the auxin transport activity of
PGP19 may be due to effects in abnormal protein abun-
dance or localization, or direct inhibition of protein activity
at the plasma membrane. Treatment of wild-type Ws
seedlings with 5 mM Gravacin for 24 hr did not affect the
overall abundance of PGP19 in microsomal fractions
(Figure 5A). In contrast to the pgp19-1 knockout [15], the
pgp19-4 line accumulates mutant protein at similar levels
as the wild-type (Figure 5A), indicating that this mutation
does not affect protein stability. We then used a GFP
Figure 4. Gravacin Binds to Microsomes that Contain Active
PGP19
(A) Gravacin displaces NPA from microsomes containing PGP19.
[3H]NPA binding was measured in microsomal fractions from Ws,
pgp19-1, pgp1, or pin1 that were incubated with 20 nM [3H]NPA in
the absence (black bars) or presence (white bars) of 100 nM Gravacin.
Data represent means ± SD (n = 3). Significant differences from wild-
type control (a) or from the NPA-alone value of the same genotype
(b) are indicated (ANOVA and Tukey post-hoc analysis: p < 0.001).
(B) Gravacin binds to microsomes containing active PGP19. Binding of
Gravacin to microsomal fractions from wild-type Ws, pgp19-1, twd1,
the parental line GFP-dTIP, and pgp19-4. Gravacin was measured
by absorbance at 348 nm. Data represent mean ± SD. Significant dif-
ferences from wild-type control (a) are indicated (ANOVA and Tukey
post-hoc analysis: p < 0.001).1372 Chemistry & Biology 14, 1366–1376, December 2007 ª20fusion to PGP19 (GFP-MDR1) [18] as well as a marker
for another plasma membrane protein, PHOT1-GFP [41],
to determine the effect of Gravacin on their localization.
Similarly to the control, 48 hr of 5 mM Gravacin treatment
resulted in accumulation of GFP-MDR1 fusion protein in
the plasma membrane. However, the fusion protein also
accumulated in an unidentified endomembrane compart-
ment that was not labeled in the control (Figure 5B). Lack
of colocalization with the endocytic marker FM4-64 indi-
cated that this punctate compartment is not endosome
(Figure S3). Thus, this abnormal localization is most likely
due to an abnormal delivery of this marker to the plasma
membrane. In comparison with the GFP-MDR1 marker,
Figure 5. Effect of Gravacin on Protein Abundance and Local-
ization
(A) Gravacin does not affect the abundance of PGP19. Equal amounts
of microsomal membrane proteins from each genotype were analyzed
by western blot using anti-PGP19 antibodies. Wild-type Ws seedlings
were treated with DMSO or 5 mMGravacin for 24 hr. The mutant alleles
pgp19-4 andpgp19-1 aswell as theGFP-dTIP controlwere not treated.
(B) Gravacin affects the subcellular localization of a PGP19 marker
(GFP-MDR1). Three-day-old seedlings from the GFP-MDR1 (top) and
PHOT1-GFP (bottom) marker lines were exposed to DMSO (left panel)
or 5 mM Gravacin (right panel) for 48 hr before inspection of root tips
under a confocal microscope. Bright punctate structures containing
GFP-MDR1 that were induced by Gravacin treatment are indicated
by arrows. The scale bars represent 10 mm.07 Elsevier Ltd All rights reserved
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served in Gravacin-treated seedlings (Figure 5B).
We have shown that PGP19 is not the target responsible
for the effect of Gravacin on trafficking of the GFP-dTIP
marker (Table 1). As expected, pgp19-4 mutants have
wild-type sensitivity to the effect of Gravacin on the traf-
ficking of the tonoplast protein marker GFP-dTIP (Fig-
ure S4). This indicates that pgp19-4 is not resistant to the
effect of Gravacin on protein trafficking, and further cor-
roborates the finding that a target other than PGP19 is im-
plicated in this phenotype of Gravacin-treated seedlings.
DISCUSSION
We provided several lines of evidence to demonstrate that
PGP19 is an important target of Gravacin, and that
PGP19, together with another target(s), participates in
the agravitropic phenotype of seedlings grown in this
chemical. First, we showed that the inhibition of basipetal
auxin transport by Gravacin in wild-type Arabidopsis
hypocotyls requires PGP19. Therefore, mutations in
PGP19 confer resistance to Gravacin, both in terms of
its effect on gravitropism and inhibition of basipetal auxin
transport, and this is not due to abnormal uptake or me-
tabolism of the chemical inside plant cells. The phenotype
of four alleles confirmed that the lesions in the PGP19 lo-
cus are responsible for the Gravacin-resistant phenotypes
of these mutants. Direct inhibition of PGP19 by Gravacin
was demonstrated when Gravacin significantly inhibited
the efflux activity of PGP19 and PGP19 + PIN1 proteins
expressed in HeLa cells. Also, NPA has been shown to
bind plasma membrane fractions containing PGP19 [14]
and yeast cells expressing PGP19 can bind NPA [15], in-
dicating that PGP19 is one target of NPA. We showed
here that PGP19 is required for Gravacin competition
with NPA for binding sites, as Gravacin was able to dis-
place NPA from NPA binding sites only in microsomes
that contained PGP19. Finally, Gravacin binds to Arabi-
dopsis microsomes from wild-type plants, but a single
amino acid change in the PGP19 protein reduced Grava-
cin binding tomicrosomes from pgp19-4mutants to levels
below the linear detection limits of the assay. The knock-
out allele pgp19-1 also exhibited reduced binding of
chemical to microsomes, but it was less severe than the
pgp19-4 allele. This mutant has been shown to upregulate
other PGP proteins to compensate for the absence of
PGP19 [20] and thus the Gravacin chemical is likely to
bind to other PGP proteins as well.
We have shown that Gravacin inhibits the auxin trans-
port activity of light-grown Arabidopsis hypocotyls to
levels similar to those seen in the pgp19-1 null allele. In
the dark, the loss of PGP19 function in the pgp19-1mutant
results in the hypertropic bending phenotype as a result of
reduced basipetal auxin transport [34], and this phenotype
is less severe in the pgp19-4 allele. However, although
Gravacin treatment resulted in completely agravitropic
growth in the wild-type, both pgp19-1 and pgp19-4 ex-
hibited Gravacin resistance as gravitropic bending was
only slightly inhibited. This indicated that PGP19 is re-Chemistry & Biology 14, 1366–137quired for the agravitropic phenotype of Gravacin-treated
seedlings and led us to the following conclusions: (1)
PGP19 is likely only one of several targets of Gravacin
that mediate gravitropism. Thus, Gravacin interactions
with other cellular components may be necessary to pre-
vent graviperception in wild-type seedlings. (2) Gravacin is
likely to affect PGP19 interactions with other proteins, as
Gravacin had the greatest impact on auxin transport in
HeLa cells coexpressing PIN1 and PGP19. Furthermore,
the pgp19-4 mutation, which abolished Gravacin binding
to PGP19, is located in the C-terminal tail previously
shown to mediate interactions with both TWD1 and PIN
[16, 20]. Thus, although Gravacin affects PGP19 interac-
tions in wild-type, basal transport of these PGP19-inter-
acting proteins, if not affected by Gravacin, may be suffi-
cient for generating the gradients necessary for hypocotyl
bending in pgp19mutants when exposed to this chemical.
(3) Compensatory increased expression ofPINs andPGPs
seen in the pgp19-1 [20] may provide sufficient basal
auxin movement in Gravacin-treated pgp19-1 seedlings
to restore gravitropism.
Our results together imply that the second nucleotide
binding domain of PGP19 and specifically E1174 are
important for the auxin transport activity of PGP19, both
in plants and in the HeLa cell system, its interaction
with PIN1, and its ability to bind Gravacin. Hence, the
E1174K substitution in the second nucleotide binding do-
main of PGP19may be sufficient for a structural change in
the loop of PGP19 that binds Gravacin and changes its
affinity for this compound. E1174 is the next residue fol-
lowing the predicted Walker B box (VLLLD) as part of
the nucleotide binding fold of this protein. This residue is
highly conserved among ABC transporters from several
organisms and has been shown to bind water and an
Mg2+ ion as part of the ATP hydrolysismechanismof these
proteins. Thus, mutations in this glutamate render other
ABC transporters inactive for ATP hydrolysis [42, 43].
The resistant phenotype of gravistimulated twd1 seed-
lings and reduced microsomal binding of these mutants
to Gravacin raises the question of whether TWD1 is also
a target of Gravacin. However, TWD1 regulates both
PGP19 and PGP1 such that if TWD1 were a target of
Gravacin, then pgp1 mutants should display a resistant
phenotype similar to that of pgp19 mutants. As pgp1mu-
tants exhibit agravitropic phenotypes in the presence of
Gravacin and Gravacin does not phenocopy the twisting
phenotype of the twd1 mutant [16], we conclude that
TWD1 is probably not a target of Gravacin. TWD1 interacts
with the C-terminal domains of PGP19 and PGP1, and is
required for PGP19 and PGP1 activity in planta [6, 16].
Yeast two-hybrid analysis indicates that the cis-trans pep-
tidylprolyl isomerase (PPIase) domain of TWD1 interacts
with the C-terminal domain of PGP19 (amino acids 965–
1252) [16] that harbors the pgp19-4 mutation. The Grava-
cin-resistant phenotype of twd1 is consistent with the
model proposed by Bouchard et al. [6], whereby TWD1
is required for conformational changes that would result
in ATP access to the second nucleotide binding domain
of PGP1 and PGP19. This phenotype suggests that6, December 2007 ª2007 Elsevier Ltd All rights reserved 1373
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is conformationally biased toward the inactive state. We
speculate that Gravacin binding to wild-type PGP19 oc-
curs primarily in the state activated by TWD1, as Grava-
cin-binding activity of twd1 microsomes is only about
60% of that of the wild-type.
Gravacin is a more specific tool for dissecting auxin
transport mechanisms because, unlike NPA, it does not
appear to affect PIN proteins and did not induce the back-
ground activity of transporters in HeLa cells. Gravacinmay
inhibit the activity of PGP19 in part by affecting its localiza-
tion, probably via reduced delivery to the plasma mem-
brane as was shown for the GFP-MDR1 marker. That
Gravacin-induced punctate bodies containing GFP-
MDR1 were not endosomal correlated well with previous
evidence that PGP19 does not appear to be regulated
by endocytic cycling at the plasma membrane [20]. How-
ever, direct inhibition of PGP19 at the plasma membrane
is also likely given the amount of GFP-MDR1 fusion pro-
tein that was present at the plasmamembrane after chem-
ical treatment. We speculate that the interaction of PGP19
with Gravacin may occur at the nucleotide binding do-
mains because of the reduced binding of Gravacin to mi-
crosomes from the pgp19-4 mutant which produces the
E1174K substitution in the second nucleotide binding do-
main of this protein. Also, few changes in the Gravacin
molecule were sufficient for the loss of the gravitropic in-
hibition, which suggests a close relationship between
PGP19 and the Gravacin molecule.
The target responsible for the effect of Gravacin on
GFP-dTIP trafficking is still unknown, but its interaction
with Gravacin occurs in a different time frame. Thus, al-
though at least 48 hr of treatment is required in seedlings
to induce this phenotype (not shown), a 2 hr treatment
was sufficient to induce changes in the transport activity
of PGP19.
SIGNIFICANCE
PGP19 is 38% identical overall and 54% identical at the
C-terminal nucleotide binding domain to the human
PGP-MDR1 (HsP-gp), the best-studied ABC trans-
porter involved in multidrug resistance of tumor cells.
Overexpression of HsP-gp in cancer cells results in
exclusion of cytotoxic drugs during treatment, and
inhibitors of HsP-gp are being analyzed for their po-
tential in cancer therapy [44]. The nucleotide binding
domains have been identified as a potent target for
P-gp inhibition given their crucial role for transport
activity [44]. The effect of Gravacin on localization
and activity of PGP19 can be potentially useful for
the development of inhibitors of HsP-gp for cancer
treatment with large implications for human health.
EXPERIMENTAL PROCEDURES
Plant Materials and Growth Conditions
The 35S:GFP-dTIP line [45] is in the Columbia (Col-0) ecotype and was
previously mutagenized by ethylmethane sulfonate (EMS) [37]. pgp19-1374 Chemistry & Biology 14, 1366–1376, December 2007 ª201, pgp1, pgp19 pgp1, and twd1 [15] mutants are in the Wassilewskija
(Ws) ecotype. mdr1-100 and mdr1-101 [39] are in the Col-0 ecotype
and were a gift from Haiyang Wang (Cornell University). The GFP-
MDR1 [18] and PHOT1-GFP [41] fusion markers were gifts from Edgar
Spalding (University of Wisconsin) andWinslow Briggs (Carnegie Insti-
tution of Washington), respectively. Wild-type Col-0 andWswere orig-
inally obtained from the Arabidopsis Biological Resource Center. All
plants were grown under long-day conditions (16/8 hr photoperiod)
at 22C under cool fluorescent lights (photosynthetic photon flux den-
sity of 120 mMm1 s1). Sterile seeds were plated on 0.53Murashige
andSkoog [46] agarmedia supplementedwith either chemical or a cor-
responding amount of DMSO (%0.1%). One percent sucrose was
used in the media except for the experiments with analogs which
were done in media without sucrose.
Chemical-Induced Phenotypes in Seedlings
and Mutant Screen
For gravitropic assays, plates were incubated in the dark at 4C for
2 days and then exposed to light for 14 hr at 22C. Plates were wrap-
ped in foil and incubated in vertical orientation for 3 days, turned 90,
and scored 24 hr later. For the resistant mutant screen, seeds were
plated on large square plates containing growth media supplemented
with 1.7 mM Gravacin and arranged individually 1–2 cm apart. Seven
hundred and eight putative resistant seedlings that responded cor-
rectly to gravitropic stimulus were transplanted to soil, but only 350
plants set viable seeds. A secondary screen yielded only 7 resistant
mutants. Hypocotyl curvatures after 24 hr gravistimulation were mea-
sured using ImageJ (National Institutes of Health) [36].
For protein abundance, seeds were plated in vertical mesh transfer
boxes [47]. Five-day-old seedlings were sprayed with 5 mM Gravacin
and incubated for 24 hr. Microsomes were prepared as described
[14] with the exception that 0.2% (v/v) b-methyl cyclodextrin was
added to the final resuspension buffer, followed by an incubation on
ice for 30 min. Samples were incubated at 37C for 30 min prior to
SDS-PAGE (8% gels) and immunoblot analysis. The immunoblot was
probed with anti-PGP19 [20] at a dilution of 1:2500, followed by anti-
rabbit IgG-horseradish peroxidase-conjugated secondary antibody
at a dilution of 1:3000 (Amersham Biosciences, Piscataway, NJ,
USA) and detected by enhanced chemiluminescent reagents (Amer-
sham Bioscience).
Chemicals Used
These chemicals were obtained from ChemBridge (San Diego, CA,
USA): Gravacin (ID 5850247), compounds A (ID 5123159), B (ID
5860541), and C (ID 5878151). Compounds D (Aldrich, St. Louis,
MO, USA; F20807-25G), E (Aldrich, 574112-5G), F (Ambinter, Paris,
France; STOCK3S-96809), and G (Aldrich, 592773-5G) were obtained
as indicated. Chemicals were dissolved in 100% DMSO as 35 mM
stocks.
Gene Mapping
Segregating F2-resistant plants were isolated using the gravitropic
assay. DNA from individual plants was isolated with Trizol reagent
(Invitrogen, Carlsbad, CA, USA), and SSLP markers [38] were used
for rough mapping.
Confocal Microscopy
Seedling roots from GFP markers were analyzed under a Leica TCS
SP2 laser-scanning confocal microscope (Leica, Wetzlar, Germany).
Auxin Transport Measurements
Basipetal auxin transport in hypocotyls was measured as previously
described [16]. All statistical analyses were done with SigmaStat (Jan-
del Scientific, Cupertino, CA, USA).
NPA and Gravacin Binding Assays
Plasma membrane-enriched microsomes from each genotype were
incubated with 0.62 mCi (20 nM) [3H]NPA (specific activity 31 Ci/mmol;07 Elsevier Ltd All rights reserved
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was estimated as described [15], but the assay was performed in the
presence of DMSO or 100 nMGravacin. For Gravacin binding, purified
microsomeswere incubated for 30min on ice with 15 mMGravacin and
collected by centrifugation at 100,000 3 g. After two additional resus-
pensions in 500 ml of buffer lacking Gravacin and subsequent recentri-
fugation, the concentration of chemical that remained in the micro-
somal pellets was estimated by absorbance at 348 nm. A standard
curve was generated for each wild-type control by measuring absor-
bance at 348 nm of solutions containing different concentrations of
Gravacin and aliquots of microsomes that had been washed three
times as described above.
HeLa Assays
Constructs of PGP19, PGP1, PIN1, and PIN2 in the pTM1 vector [48]
for expression in HeLa cells have been described [6, 9, 20]. For expres-
sion of the pgp19E1174K protein, the pTM1 construct containing the
PGP19-HA cDNA fusion was site-specific mutagenized using the
Quikchange II XL site-directed mutagenesis kit (Stratagene, La Jolla,
CA, USA). The [3H]IAA transport assays were performed as previously
described [7], except that 5 mM Gravacin or 5 mM NPA was added to
the transfected/infected HeLa cells and incubated for 2 hr prior to
the assay.
Supplemental Data
Supplemental Data include four figures and Supplemental Experimen-
tal Procedures and can be found with this article online at http://www.
chembiol.com/cgi/content/full/14/12/1366/DC1/.
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